Financials
- Market Capitalization 27.42 B
- Employee 100
- Founded 1996
- CEO N/A
- Website www.royaltypharma.com
- Headquarter United Kingdom
- FIGI N/A
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
29.98
Relación precio/flujo de caja
12.37
Dividendos por acción
0.47
Rendimiento por dividendo, %
4
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 355 | RVMD Revolution Medicines, Inc. - Common Stock | 205.57 USD | -1.11% | -4.06% | +11.46% | +271.06% | 44.06 B USD | ||
| 438 | ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | 240.69 USD | +1.51% | +1.75% | +15.69% | -46.01% | 32.21 B USD | ||
| 491 | INSM Insmed Incorporated - Common Stock | 121.82 USD | +2.77% | -2.14% | +24.05% | -24.83% | 26.60 B USD | ||
| 512 | ROIV Roivant Sciences Ltd. - Common Shares | 34.64 USD | -0.20% | -6.18% | +4.40% | +89.19% | 25.02 B USD |